What are the next steps for liposomal chemotherapy delivery and CPX-351? - 101793

Spotlight
Video

What are the next steps for liposomal chemotherapy delivery and CPX-351?

VJHemOnc has 1073 videos Subscribe Here

Loading........
Description: The liposomal delivery of chemotherapy is a promising therapeutic area, which was highlighted by the approval of CPX-351 for two types of typically hard-to-treat secondary acute myeloid leukemia (AML). In this interview, Jeffrey Lancet, MD, of the Moffitt Cancer Center, Tampa, FL, discusses the diverse next steps in this field. Dr Lancet covers identifying responders, investigating the drug’s effect on transplant success and potential combinations with targeted therapy. This video was recorded at the 1st International Workshop on Acute Leukemias (iwAL), held in St. Pete Beach, FL.
Shared By : VJHemOnc
Posted on : 03/08/18
Added : 3 months ago